Showing results (451-460 of 878) with videos related to
Sort By:
Pageof 88
JACC. Cardiovascular Interventions|October 23, 2010
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registriesCihan Simsek, Michael Magro, Eric Boersma, et al.American Heart Journal|March 5, 2004
Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapyEvert J P Lamfers, Astrid Schut, Don P Hertzberger, et al.Archives of Internal Medicine|July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.Archives of Physical Medicine and Rehabilitation|January 7, 2020
Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled TrialMarie de Bakker, Iris den Uijl, Nienke Ter Hoeve, et al.Atherosclerosis|August 31, 2020
The age- and sex-specific composition of atherosclerotic plaques in vascular surgery patientsMarie de Bakker, Nathalie Timmerman, Ian D van Koeverden, et al.Journal of the American College of Cardiology|September 5, 2006
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkersCynthia M Westerhout, Yuling Fu, Michael S Lauer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patientsClaudia Ypenburg, Martin J Schalij, Gabe B Bleeker, et al.Heart (British Cardiac Society)|September 8, 2019
Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertensionLaurie W Geenen, Vivan J M Baggen, Robert M Kauling, et al.European Heart Journal|May 14, 2011
Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participantsSanneke P M de Boer, Mattie J Lenzen, Rohit M Oemrawsingh, et al.American Heart Journal|December 24, 2018
The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approachLaurie W Geenen, Vivan J M Baggen, Thomas Koudstaal, et al.Pageof 88